These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 2484088)

  • 21. Reduction of dispersion of repolarization and prolongation of postrepolarization refractoriness explain the antiarrhythmic effects of quinidine in a model of short QT syndrome.
    Milberg P; Tegelkamp R; Osada N; Schimpf R; Wolpert C; Breithardt G; Borggrefe M; Eckardt L
    J Cardiovasc Electrophysiol; 2007 Jun; 18(6):658-64. PubMed ID: 17521304
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antiarrhythmic effect of a sotalol-mexiletine combination on induced ventricular tachycardia in dogs.
    Chézalviel F; Weissenburger J; Guhennec C; Jagueux M; Davy JM; Vernhet L; Simandoux V; Poirier JM; Cheymol G
    J Cardiovasc Pharmacol; 1993 Feb; 21(2):212-20. PubMed ID: 7679154
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sotalol: An important new antiarrhythmic.
    Anderson JL; Prystowsky EN
    Am Heart J; 1999 Mar; 137(3):388-409. PubMed ID: 10047618
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Action of sotalol on potential reentrant pathways and ventricular tachyarrhythmias in conscious dogs in the late postmyocardial infarction phase.
    Cobbe SM; Hoffman E; Ritzenhoff A; Brachmann J; Kübler W; Senges J
    Circulation; 1983 Oct; 68(4):865-71. PubMed ID: 6616781
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dispersion of ventricular refractoriness in experimental myocardial infarction: effect of sotalol.
    Lubiński A; Hindricks G; Shenasa M; Haverkamp W; Vogt B; Borggrefe M; Breithardt G
    Pacing Clin Electrophysiol; 1994 Nov; 17(11 Pt 2):2090-4. PubMed ID: 7845823
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of the effects of chronic oral therapy with atenolol and sotalol on ventricular monophasic action potential duration and effective refractory period.
    Way BP; Forfar JC; Cobbe SM
    Am Heart J; 1988 Sep; 116(3):740-6. PubMed ID: 3046277
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Electropharmacodynamics of N-acetylprocainamide in the immature mammalian heart--evidence for a prominent class III effect in the newborn.
    Dise T; Stolfi A; Yamasaki S; Pickoff AS
    J Cardiovasc Pharmacol; 1991 Jan; 17(1):96-101. PubMed ID: 1708063
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical electrophysiology of intravenous sotalol, a beta-blocking drug with class III antiarrhythmic properties.
    Touboul P; Atallah G; Kirkorian G; Lamaud M; Moleur P
    Am Heart J; 1984 May; 107(5 Pt 1):888-95. PubMed ID: 6720518
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative mechanisms of antiarrhythmic drug action in experimental atrial fibrillation. Importance of use-dependent effects on refractoriness.
    Wang J; Bourne GW; Wang Z; Villemaire C; Talajic M; Nattel S
    Circulation; 1993 Sep; 88(3):1030-44. PubMed ID: 8353865
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sodium channel block by ranolazine in an experimental model of stretch-related atrial fibrillation: prolongation of interatrial conduction time and increase in post-repolarization refractoriness.
    Milberg P; Frommeyer G; Ghezelbash S; Rajamani S; Osada N; Razvan R; Belardinelli L; Breithardt G; Eckardt L
    Europace; 2013 May; 15(5):761-9. PubMed ID: 23376977
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A comparison of electrophysiologic properties between responders and non-responders to DL-sotalol among patients with ventricular tachyarrhythmia. Importance of the lack of a reverse use-dependent effect on ventricular refractoriness to responders.
    Naitoh N; Yamaura M; Tagawa M; Aizawa Y
    Jpn Heart J; 1998 Sep; 39(5):619-30. PubMed ID: 9925993
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effects of verapamil on the electrophysiology of the intact immature mammalian heart.
    Pickoff AS; Flinn CJ; Singh S; Gelband H
    J Cardiovasc Pharmacol; 1985; 7(1):125-30. PubMed ID: 2580132
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antiarrhythmic and electrophysiologic effects of MDL 11,939, a novel class III antiarrhythmic agent in anesthetized dogs.
    Koerner JE; Dage RC
    J Cardiovasc Pharmacol; 1990 Sep; 16(3):383-93. PubMed ID: 1700208
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparability of the electrophysiologic responses and plasma and myocardial tissue concentrations of sotalol and its d stereoisomer in the dog.
    Gomoll AW; Lekich RF; Bartek MJ; Comereski CR; Antonaccio MJ
    J Cardiovasc Pharmacol; 1990 Aug; 16(2):204-11. PubMed ID: 1697375
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Positive and negative inotropic effects of DL-sotalol and D-sotalol in failing and nonfailing human myocardium under physiological experimental conditions.
    Holubarsch C; Schneider R; Pieske B; Ruf T; Hasenfuss G; Fraedrich G; Posival H; Just H
    Circulation; 1995 Nov; 92(10):2904-10. PubMed ID: 7586258
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prolonged ventricular refractoriness and action potential duration after beta-adrenoreceptor blockade in the dog heart in situ.
    Amlie JP; Refsum H; Landmark KH
    J Cardiovasc Pharmacol; 1982; 4(1):157-62. PubMed ID: 6176793
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prolongation of the human cardiac monophasic action potential by sotalol.
    Echt DS; Berte LE; Clusin WT; Samuelsson RG; Harrison DC; Mason JW
    Am J Cardiol; 1982 Nov; 50(5):1082-6. PubMed ID: 6127944
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of elevated extracellular potassium concentrations on the class III antiarrhythmic action of sotalol.
    Cobbe SM; Manley BS
    Cardiovasc Res; 1985 Feb; 19(2):69-75. PubMed ID: 3978667
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Electrophysiological effects of intravenous sotalol in acute myocardial infarction: a double-blind placebo-controlled study.
    Aström M; Edhag O; Nyquist O; Vallin H
    Eur Heart J; 1990 Jan; 11(1):35-42. PubMed ID: 2407533
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasma concentrations and haemodynamic effects of d-sotalol after beta-blockade in dogs.
    Mortensen E; Tande PM; Kløw NE; Refsum H
    Pharmacol Toxicol; 1990 Nov; 67(5):420-5. PubMed ID: 1982898
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.